CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINED RELEASE OF LOW-SOLUBILITY DRUG - Patent 1789022

(19)

(11)

EP 1 789 022 A2

(12)

(88)	Date of publication A3:
	04.05.2006

(43)	Date of publication:
	30.05.2007 Bulletin 2007/22

(21)	Application number: 05782784.2

(22)	Date of filing: 19.08.2005

(51)

International Patent Classification (IPC):

A61K 9/20^(2006.01)

(86)	International application number:
	PCT/IB2005/002825

(87)	International publication number:
	WO 2006/024949 (09.03.2006 Gazette 2006/10)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

31.08.2004 US 605955 P

(71)	Applicant: Pfizer Products Incorporated
	Groton, CT 06340 (US)

(72)	Inventors:
	APPEL, Leah Elizabeth Bend, OR 97701 (US) FRIESEN, Dwayne Thomas Bend, OR 97701 (US) HERBIG, Scott Max Groton, CT 06340 (US) THOMBRE, Avinash Govind Groton, CT 06340 (US)

(74)	Representative: Kendrick, David Alan et al
	Pfizer Limited European Patent Department (IPC 748) Ramsgate Road GB-Sandwich, Kent CT13 9NJ GB-Sandwich, Kent CT13 9NJ (GB)

(54)	CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINED RELEASE OF LOW-SOLUBILITY DRUG